Advertiment
Matrix Metalloproteinase Inhibitors in Cancer Therapy - Cancer Drug Discovery and Development)
The association of matrix metalloproteinases (MMPs)-enzymes that disrupt the body’s normal repair functions-with several diseases, including growing and invasive tumors, holds the tantalizing promise that their inhibiton might have therapeutic value. In Matrix Metalloproteinase Inhibitors in Cancer Therapy, cutting-edge investigators review the current status of the entire field, from the biology of MMPs through the current clinical studies. The authors include many leading scientists from pharmaceutical companies who present all the latest concepts and results on the preferred design strategies for MMP inhibitors, their molecular mechanisms, and their substrates. In addition, they fully describe their company’s research effort on specific MMP inhibitors, detailing vanguard design strategies, their in vitro activity, the outcome of animal model studies and, where available, their toxicology, safety, and efficacy in human clinical trials. Comprehensive and state-of-the-art, Matrix Metalloproteinase Inhibitors offers basic and clinical investigators alike a richly informative summary of all the latest research on these powerful new drugs, and their high promise as emerging cancer therapeutics.
Paperback: 276 pages
Publisher: Humana Press; Softcover reprint of hardcover 1st ed. 2001 edition (July 1, 2011)
Language: English
ISBN-10: 1617371238
ISBN-13: 978-1617371233
Matrix Metalloproteinase Inhibitors in Cancer Therapy – Cancer Drug Discovery and Development
Leave a Reply
Suggested Posts
Lung Cancer: A Multidisciplinary Approach The associatio of matrix metalloprotei ases (MMPs)-e zymes that disrupt the body’s ormal repair fu ctio s-with several diseases, i cludi g growi g a d i vasive tumors, holds the ta talizi g promise that their i hibito might have therapeutic value. I Matrix Metalloprotei ase I hibitors i Ca cer Therapy, cutti g-edge i vestigators review the curre t status of the e tire field, from the biology of MMPs through the [...]. Posted June 2nd, 2011 | 8:31 pm
Clinical Dilemmas in Primary Liver Cancer The associatio of matrix metalloprotei ases (MMPs)-e zymes that disrupt the body’s ormal repair fu ctio s-with several diseases, i cludi g growi g a d i vasive tumors, holds the ta talizi g promise that their i hibito might have therapeutic value. I Matrix Metalloprotei ase I hibitors i Ca cer Therapy, cutti g-edge i vestigators review the curre t status of the e tire field, from the biology of MMPs through the [...]. Posted June 2nd, 2011 | 8:31 pm
Neuropsychology of Cancer and Oncology The associatio of matrix metalloprotei ases (MMPs)-e zymes that disrupt the body’s ormal repair fu ctio s-with several diseases, i cludi g growi g a d i vasive tumors, holds the ta talizi g promise that their i hibito might have therapeutic value. I Matrix Metalloprotei ase I hibitors i Ca cer Therapy, cutti g-edge i vestigators review the curre t status of the e tire field, from the biology of MMPs through the [...]. Posted June 2nd, 2011 | 8:31 pm
Head and Neck Surgery and Oncology, 4 Edition The associatio of matrix metalloprotei ases (MMPs)-e zymes that disrupt the body’s ormal repair fu ctio s-with several diseases, i cludi g growi g a d i vasive tumors, holds the ta talizi g promise that their i hibito might have therapeutic value. I Matrix Metalloprotei ase I hibitors i Ca cer Therapy, cutti g-edge i vestigators review the curre t status of the e tire field, from the biology of MMPs through the [...]. Posted June 2nd, 2011 | 8:31 pm
Hematology-Oncology Therapy, Second Edition The associatio of matrix metalloprotei ases (MMPs)-e zymes that disrupt the body’s ormal repair fu ctio s-with several diseases, i cludi g growi g a d i vasive tumors, holds the ta talizi g promise that their i hibito might have therapeutic value. I Matrix Metalloprotei ase I hibitors i Ca cer Therapy, cutti g-edge i vestigators review the curre t status of the e tire field, from the biology of MMPs through the [...]. Posted June 2nd, 2011 | 8:31 pm